IP Library Granted Patent US 8,932,255
Granted Patent B1
US 8,932,255 · App. 11/677,946 · Granted Jan 13, 2015

Methods for using front-loading medical fluid injector

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,932,255
App. No.
11/677,946
Granted
Jan 13, 2015
Kind
B1
Abstract

Various sealing structures are used in a front-loading injector, for preventing leakage of spilled fluid from an external surface of a syringe into the vicinity of the drive ram. For example, a sealing gasket may be incorporated into the front face of the injector housing, for mating to the rearward circular edge of the cylindrical body of a syringe. Alternatively, sealing and locking functions may be performed by a single structure on the rearward end of the syringe. Further, leakage may be prevented by including a non-planar sealing flange on the syringe, positioned on the syringe forward of the locking structure, or by a two-piece structure, including a syringe and a separate leakage stopping washer for surrounding the syringe to halt the flow of fluid along the exterior of the syringe. (As part of this aspect, or as an independent feature, the syringe may include an annularly discontinuous flange forward of the locking structure, for providing mechanical support for the syringe against the injector.) Alternatively, an iris-like structure may be incorporated into the front surface of the injector, for closing about the syringe upon insertion of the syringe into the injector.

Claims (52)

1. A method of using a front-loading, medical fluid injector, the method comprising:

rotating a syringe relative to the injector, wherein the rotating is accomplished in opposition to a spring force provided by the injector; and

moving an arcuate section of a syringe mounting mechanism of the injector relative to a housing of the injector, wherein the moving is due, at least in part, to the rotating, wherein the arcuate section of the syringe mounting mechanism moves toward the syringe due to rotation of the syringe in a first direction and away from the syringe due to rotation of the syringe in a second direction substantially opposite the first direction.

2. The method of claim 1 , wherein the syringe mounting mechanism comprises an iris-like structure.

3. The method of claim 2 , wherein the moving comprises moving first and second arms of the iris-like structure relative to the housing of the injector, wherein the first arm of the iris-like structure comprises the arcuate section.

4. The method of claim 1 , wherein the moving comprises pivoting the arcuate section.

5. The method of claim 1 , wherein the moving comprises translating the arcuate section.

6. The method of claim 1 , wherein the moving comprises moving the arcuate section laterally with respect to an axis of the syringe.

7. The method of claim 1 , wherein the moving comprises moving the arcuate section toward the syringe by rotating the syringe in the first direction.

8. The method of claim 1 , wherein the moving comprises pivoting the arcuate section toward the syringe by rotating the syringe in the first direction.

9. The method of claim 1 , wherein the moving comprises translating the arcuate section toward the syringe by rotating the syringe in the first direction.

10. The method of claim 1 , wherein the moving comprises moving the arcuate section laterally toward an axis of the syringe by rotating the syringe in the first direction.

11. The method of claim 1 , further comprising:

contacting the syringe with an inside radius of curvature of the arcuate section as a result of the rotation of the syringe in the first direction for the moving.

12. The method of claim 1 , wherein the arcuate section is substantially semicircular.

13. The method of claim 1 , wherein the spring force provided by the injector biases the arcuate section of the syringe mounting mechanism toward an open position in which the syringe can be withdrawn from an opening in the injector.

14. The method of claim 1 , wherein the spring force provided by the injector biases the arcuate section toward an open position in which the arcuate section is disengaged from the syringe.

15. The method of claim 1 , wherein the arcuate section pivots toward the syringe due to rotation of the syringe in the first direction and away from the syringe due to rotation of the syringe in the second direction substantially opposite the first direction.

16. The method of claim 1 , wherein the arcuate section translates toward the syringe due to rotation of the syringe in the first direction and away from the syringe due to rotation of the syringe in the second direction substantially opposite the first direction.

17. The method of claim 1 , wherein the spring force is oriented in opposition of syringe rotation in the first direction.

18. The method of claim 1 , wherein the spring force biases the arcuate section toward an open position in which the arcuate section is disengaged from the syringe.

19. The method of claim 18 , wherein, as a result of rotation of the syringe in the first direction relative to the injector, the arcuate section is in a closed position in which the arcuate section is engaged with the syringe.

20. The method of claim 19 , wherein, as a result of rotation of the syringe in the second direction substantially opposite the first direction, the arcuate section is in the open position.

21. The method of claim 1 , wherein the moving comprises moving first and second arcuate sections of the syringe mounting mechanism relative to the housing of the injector, and wherein the first arcuate section comprises the arcuate section.

22. The method of claim 21 , wherein the moving of the first and second arcuate sections comprises pivoting each of the first and second arcuate sections.

23. The method of claim 21 , wherein the moving of the first and second arcuate sections comprises translating each of the first and second arcuate sections.

24. The method of claim 21 , wherein the moving of each of the first and second arcuate sections is in a direction substantially perpendicular to an axis of the syringe.

25. The method of claim 21 , wherein the first and second arcuate sections are not integral with one another.

26. The method of claim 21 , wherein the moving of each of the first and second arcuate sections, by rotating the syringe in the first direction, is toward an axis of the syringe.

27. The method of claim 21 , wherein the moving, by rotating the syringe in the first direction, occurs until both the first and second arcuate sections contact the syringe.

28. The method of claim 21 , wherein the spring force provided by the injector biases the first and second arcuate sections toward an open position in which the syringe can be withdrawn from an opening in the injector.

29. The method of claim 21 , wherein the spring force provided by the injector biases the first and second arcuate sections toward an open position in which the first and second arcuate sections are disengaged from the syringe.

30. The method of claim 21 , wherein, as a result of rotation of the syringe in the first direction relative to the injector, the first and second arcuate sections are in a closed position in which each of the first and second arcuate sections is engaged with the syringe.

31. The method of claim 30 , wherein, as a result of rotation of the syringe in the second direction substantially opposite the first direction, the first and second arcuate sections are in the open position.

32. The method of claim 21 , wherein each of the first and second arcuate sections is designed to move toward the syringe due to rotation of the syringe in the first direction and away from the syringe due to rotation of the syringe in the second direction substantially opposite the first direction.

33. The method of claim 32 , wherein each of the first and second arcuate sections is designed to pivot toward the syringe due to rotation of the syringe in the first direction and away from the syringe due to rotation of the syringe in the second direction substantially opposite the first direction.

34. The method of claim 32 , wherein each of the first and second arcuate sections is designed to translate toward the syringe due to rotation of the syringe in the first direction and away from the syringe due to rotation of the syringe in the second direction substantially opposite the first direction.

35. The method of claim 32 , wherein the spring force is oriented in opposition of syringe rotation in the first direction.

36. The method of claim 1 , wherein the spring force is provided by first and second springs of the injector.

37. The method of claim 1 , wherein the spring force is provided by a torsion spring of the injector.

38. The method of claim 1 , wherein the spring force is provided by a coil spring of the injector.

39. The method of claim 1 , wherein the injector comprises a cam that is in contact with the syringe during the rotating, and the spring force is transferred via the cam to the syringe.

40. The method of claim 39 , wherein the cam pivots relative to the injector in response to the rotating.

41. The method of claim 1 , wherein the rotating occurs while at least a rearward end of a barrel of the syringe is located within an opening defined in the injector.

42. The method of claim 41 , wherein the opening is defined in a face plate of the injector.

43. The method of claim 1 , wherein the rotating occurs while at least a rearward portion of a barrel of the syringe is in contact with the injector and while a plunger of the syringe is substantially aligned with a drive ram of the injector.

44. A method of using a front-loading, medical fluid injector, the method comprising:

rotating a syringe relative to the injector, wherein the rotating is accomplished in opposition to a spring force provided by the injector; and

moving an arcuate section of a syringe mounting mechanism of the injector relative to a housing of the injector, wherein the moving is due, at least in part, to the rotating, and wherein the spring force provided by the injector biases the arcuate section of the syringe mounting mechanism toward an open position in which the syringe can be withdrawn from an opening in the injector.

45. A method of using a front-loading, medical fluid injector, the method comprising:

rotating a syringe relative to the injector, wherein the rotating is accomplished in opposition to a spring force provided by the injector; and

moving an arcuate section of a syringe mounting mechanism of the injector relative to a housing of the injector, wherein the moving is due, at least in part, to the rotating, and wherein the spring force provided by the injector biases the arcuate section toward an open position in which the arcuate section is disengaged from the syringe.

Assignments (3)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
RELEASE OF SECURITY INTEREST Recorded Nov 30, 2015
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: LIEBEL-FLARSHEIM COMPANY LLC
Reel/Frame 037172/0094 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →